CVM Message Board Post 8893514 | Cel-Sci Corporation...
home / stock / cvm / cvm message board
lcraw2016
(investorshub)
Posted on: Apr/12/2023 14:17:59
Source: investorshub
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=171666722
Hey Kids! Its Math time!
News, Short Squeeze, Breakout and More Instantly...
-
CEL-SCI Corporation (NYSE American: CVM) today announced that Robert (“Bob”) Watson, who has served as a Director of the Company since 2017, has been appointed Chairperson of the Board. Bob is an accomplished business leader who began his career as an investment banker. Wi...
-
Multikine significantly increases overall survival in patients with low levels of tumor cell PD-L1 expression in contrast to approved checkpoint inhibitors 73% survival for Multikine vs 45% in the control arm at 5 years Statistically significant log rank p = 0.0015 ...
-
Dr. Selvaggi was instrumental in the development and approval of lung cancer drugs Zykadia for Novartis and Opdivo for Bristol Myers Squibb CEL-SCI’s Multikine immunotherapy improves the 5-year survival of head and neck cancer patients to 73% compared to 45% in controls and cut...